[ad_1]
The preparation developed by Hungary against the coronavirus prevents serious diseases based on animal tests – Imre Kacskovics, dean of the Faculty of Sciences of the Eötvös Loránd University, reported Tuesday. Radio Kossuth Good morning Hungary! in your program.
According to the MTI report, the head of the drug development consortium told the show that experts from Richter Gedeon Plc. According to the expert, cell experiments have shown that
With the use of the new drug, the virus is unable to infect.
This was followed by animal experiments, which were also encouraging, as the drug did not cause severe symptoms in coronavirus-infected hamsters. These animal experiments will be repeated several more times, followed by toxicological studies and human clinical trials scheduled for late fall.
The drug is a type of ‘antibody’ that the body produces as a result of vaccination, so
It doesn’t take a month for protection to develop, but it makes the body resilient 12 hours after injection.
Imre Kacskovics pointed out. He added that in the case of those who are at risk, that is, the elderly or those suffering from a chronic disease, it is worth using the new drug already in the mild to moderate phase of the infection. Serious illnesses cannot be treated with medication and will therefore have a preventive role.
[ad_2]
